N-cyclohexyl-3-(4-oxo-3H-quinazolin-2-yl)propanamide
98%
- Product Code: 245784
CAS:
626222-52-4
| Molecular Weight: | 299.37 g./mol | Molecular Formula: | C₁₇H₂₁N₃O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | 1.30±0.1 g/cm3(Predicted) | Storage Condition: | -20°C, Sealed, Dry |
Product Description:
Used in pharmaceutical research as a key intermediate for synthesizing kinase inhibitors, particularly in the development of anticancer agents. Shows potential in modulating signaling pathways involved in tumor growth and cell proliferation. Also explored for its anti-inflammatory properties due to structural similarity to known bioactive quinazoline derivatives. Employed in structure-activity relationship (SAR) studies to optimize potency and selectivity in drug candidates.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿4,170.00 |
+
-
|
| 0.025 | 10-20 days | ฿13,190.00 |
+
-
|
| 0.050 | 10-20 days | ฿20,890.00 |
+
-
|
N-cyclohexyl-3-(4-oxo-3H-quinazolin-2-yl)propanamide
Used in pharmaceutical research as a key intermediate for synthesizing kinase inhibitors, particularly in the development of anticancer agents. Shows potential in modulating signaling pathways involved in tumor growth and cell proliferation. Also explored for its anti-inflammatory properties due to structural similarity to known bioactive quinazoline derivatives. Employed in structure-activity relationship (SAR) studies to optimize potency and selectivity in drug candidates.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :